IP Library Granted Patent US 9,642,747
Granted Patent B2
US 9,642,747 · App. 14/823,864 · Granted May 9, 2017

Endpoint-managed photocoagulation

Inventor: Chris Sramek (Sunnyvale, CA)
Assignee: TOPCON MEDICAL LASER SYSTEMS, INC.
A61F9/00821A61F2009/00855A61F2009/00863
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,642,747
App. No.
14/823,864
Granted
May 9, 2017
Kind
B2
Abstract

Systems and processes are described relating to laser-based ophthalmic intervention technologies and, more specifically, to techniques for delivering reproducible amounts of laser energy to create visible and sub-visible lesions on an eye. The subject technology may provide a user with the ability to adjust the amount of energy to be delivered to the eye tissue by selecting a single numerical value. In response, the system may adjust the power and/or duration of the laser treatment beam pulse according to an operating curve determined by the system.

Claims (107)

1. A method for laser treatment of an eye of a patient, the method comprising:

receiving a laser treatment beam power and a laser treatment beam duration representing a dose of laser energy adapted to produce a first type of detectable lesion on the eye;

determining a first Arrhenius integral value based on the received laser treatment beam power and laser treatment beam duration;

determining a set of data points that define a first constant-Arrhenius curve corresponding to the first Arrhenius integral value,

wherein the set of data points that define the first constant-Arrhenius curve represents combinations of laser treatment beam power and laser treatment beam duration adapted to produce the first type of detectable lesion;

determining a set of data points that define a second constant-Arrhenius curve corresponding to a second Arrhenius integral value,

wherein the second Arrhenius integral value has a logarithmic relationship to the first Arrhenius integral value,

wherein the set of data points that define the second constant-Arrhenius curve represents combinations of laser treatment beam power and laser treatment beam duration adapted to produce a second type of detectable lesion, and

wherein the first type and the second type of detectable lesion have different types of clinical results;

determining a set of data points that define an operating curve for a laser treatment beam,

wherein the operating curve intersects the first and second constant-Arrhenius curves, and

wherein the set of data points that define the operating curve represents selectable combinations of laser treatment beam power and laser treatment beam duration configured to be output by a laser energy source for delivering doses of laser energy;

receiving a selection corresponding to a data point of the set of data points that define the operating curve;

in response to receiving the selection, adjusting at least one of a power and a duration of the laser treatment beam in accordance with the laser treatment beam power and the laser treatment beam duration represented by the selected data point of the operating curve; and

outputting the laser treatment beam using the laser energy source.

2. The method of claim 1 , wherein receiving the laser treatment beam power and the laser treatment beam duration representing a dose of laser energy adapted to produce the first type of detectable lesion comprises:

receiving selection of a maximum laser treatment beam duration; and

adjusting the laser treatment beam power to a power adapted to produce the first type of detectable lesion when applied at the maximum laser treatment beam duration,

wherein the maximum laser treatment beam duration and the adjusted laser treatment beam power are used to determine the first Arrhenius integral value.

3. The method of claim 1 , wherein receiving the laser treatment beam power and the laser treatment beam duration representing a dose of laser energy adapted to produce the first type of detectable lesion comprises:

receiving selection of a maximum laser treatment beam power; and

adjusting the laser treatment beam duration to a duration adapted to produce the first type of detectable lesion when applied at the maximum laser treatment beam power,

wherein the maximum laser treatment beam power and the adjusted laser treatment beam duration are used to determine the first Arrhenius integral value.

4. The method of claim 1 , wherein adjusting at least one of the power and the duration of the laser treatment beam comprises:

adjusting the power of the laser treatment beam, wherein the duration of the laser treatment beam is kept constant.

5. The method of claim 1 , wherein adjusting at least one of the power and the duration of the laser treatment beam comprises:

adjusting the duration of the laser treatment beam, wherein the power of the laser treatment beam is kept constant.

6. The method of claim 1 , further comprising:

receiving a selection of a laser treatment beam diameter; and

in response to receiving the selection of the laser treatment beam diameter, adjusting the diameter of the laser treatment beam.

7. The method of claim 1 , wherein the dose of laser energy adapted to produce the first type of detectable lesion represents a maximum energy value of the operating curve.

8. The method of claim 1 , wherein the operating curve relates linear changes in energy value to exponential changes in Arrhenius integral values.

9. The method of claim 8 , wherein receiving the selection corresponding to the data point of the set of data points that define the operating curve comprises:

receiving selection of a normalized energy value from a linear numerical scale of normalized energy values.

10. The method of claim 1 , wherein at least one of the first type and the second type of detectable lesion is a sub-visible lesion.

11. A system for laser treatment of an eye of a patient, the system comprising:

a laser energy source configured to generate a laser treatment beam; and

a computer processor configured to:

receive a laser treatment beam power and a laser treatment beam duration representing a dose of laser energy adapted to produce a first type of detectable lesion on the eye;

determine a first Arrhenius integral value based on the received laser treatment beam power and laser treatment beam duration;

determine a set of data points that define a first constant-Arrhenius curve corresponding to the first Arrhenius integral value,

wherein the set of data points that define the first constant-Arrhenius curve represents combinations of laser treatment beam power and laser treatment beam duration adapted to produce the first type of detectable lesion;

determine a set of data points that define a second constant-Arrhenius curve corresponding to a second Arrhenius integral value,

wherein the second Arrhenius integral value has a logarithmic relationship to the first Arrhenius integral value,

wherein the set of data points that define the second constant-Arrhenius curve represents combinations of laser treatment beam power and laser treatment beam duration adapted to produce a second type of detectable lesion, and

wherein the first type and the second type of detectable lesion have different types of clinical results;

determine a set of data points that define an operating curve for a laser treatment beam,

wherein the operating curve intersects the first and second constant-Arrhenius curves, and

wherein the set of data points that define the operating curve represents selectable combinations of laser treatment beam power and laser treatment beam duration configured to be output by a laser energy source for delivering doses of laser energy;

receive a selection corresponding to a data point of the set of data points that define the operating curve;

in response to receiving the selection, adjust at least one of a power and a duration of the laser treatment beam in accordance with the laser treatment beam power and the laser treatment beam duration represented by the selected data point of the operating curve; and

output the laser treatment beam using the laser energy source.

12. The system of claim 11 , wherein receiving the laser treatment beam power and the laser treatment beam duration representing a dose of laser energy adapted to produce the first type of detectable lesion comprises:

receiving selection of a maximum laser treatment beam duration; and

adjusting the laser treatment beam power to a power adapted to produce the first type of detectable lesion when applied at the maximum laser treatment beam duration,

wherein the maximum laser treatment beam duration and the adjusted laser treatment beam power are used to determine the first Arrhenius integral value.

13. The system of claim 11 , wherein receiving the laser treatment beam power and the laser treatment beam duration representing a dose of laser energy adapted to produce the first type of detectable lesion comprises:

receiving selection of a maximum laser treatment beam power; and

adjusting the laser treatment beam duration to a duration adapted to produce the first type of detectable lesion when applied at the maximum laser treatment beam power,

wherein the maximum laser treatment beam power and the adjusted laser treatment beam duration are used to determine the first Arrhenius integral value.

14. The system of claim 11 , wherein adjusting at least one of the power and the duration of the laser treatment beam comprises:

adjusting the power of the laser treatment beam, wherein the duration of the laser treatment beam is kept constant.

15. The system of claim 11 , wherein adjusting at least one of the power and the duration of the laser treatment beam comprises:

adjusting the duration of the laser treatment beam, wherein the power of the laser treatment beam is kept constant.

16. The system of claim 11 , wherein the computer processor is further configured to:

receive a selection of a laser treatment beam diameter; and

in response to receiving the selection of the laser treatment beam diameter, adjust the diameter of the laser treatment beam.

17. The system of claim 11 , wherein the dose of laser energy adapted to produce the first type of detectable lesion represents a maximum energy value of the operating curve.

18. The system of claim 11 , wherein the operating curve relates linear changes in energy value to exponential changes in Arrhenius integral values.

19. The system of claim 18 , wherein receiving the selection corresponding to the data point of the set of data points that define the operating curve comprises:

receiving selection of a normalized energy value from a linear numerical scale of normalized energy values.

20. The system of claim 11 , wherein at least one of the first type and the second type of detectable lesion is a sub-visible lesion.

21. A non-transitory computer-readable storage medium having computer-executable instructions for treating an eye of a patient using a laser treatment beam, the computer-executable instructions comprising instructions for:

receiving a laser treatment beam power and a laser treatment beam duration representing a dose of laser energy adapted to produce a first type of detectable lesion on the eye;

determining a first Arrhenius integral value based on the received laser treatment beam power and laser treatment beam duration;

determining a set of data points that define a first constant-Arrhenius curve corresponding to the first Arrhenius integral value,

wherein the set of data points that define the first constant-Arrhenius curve represents combinations of laser treatment beam power and laser treatment beam duration adapted to produce the first type of detectable lesion;

determining a set of data points that define a second constant-Arrhenius curve corresponding to a second Arrhenius integral value,

wherein the second Arrhenius integral value has a logarithmic relationship to the first Arrhenius integral value,

wherein the set of data points that define the second constant-Arrhenius curve represents combinations of laser treatment beam power and laser treatment beam duration adapted to produce a second type of detectable lesion, and

wherein the first type and the second type of detectable lesion have different types of clinical results;

determining a set of data points that define an operating curve for a laser treatment beam,

wherein the operating curve intersects the first and second constant-Arrhenius curves, and

wherein the set of data points that define the operating curve represents selectable combinations of laser treatment beam power and laser treatment beam duration configured to be output by a laser energy source for delivering doses of laser energy;

receiving a selection corresponding to a data point of the set of data points that define the operating curve;

in response to receiving the selection, adjusting at least one of a power and a duration of the laser treatment beam in accordance with the laser treatment beam power and the laser treatment beam duration represented by the selected data point of the operating curve; and

outputting the laser treatment beam using the laser energy source.

22. The non-transitory computer-readable storage medium of claim 21 , wherein receiving the laser treatment beam power and the laser treatment beam duration representing a dose of laser energy adapted to produce the first type of detectable lesion comprises:

receiving selection of a maximum laser treatment beam duration; and

adjusting the laser treatment beam power to a power adapted to produce the first type of detectable lesion when applied at the maximum laser treatment beam duration,

wherein the maximum laser treatment beam duration and the adjusted laser treatment beam power are used to determine the first Arrhenius integral value.

23. The non-transitory computer-readable storage medium of claim 21 , wherein receiving the laser treatment beam power and the laser treatment beam duration representing a dose of laser energy adapted to produce the first type of detectable lesion comprises:

receiving selection of a maximum laser treatment beam power; and

adjusting the laser treatment beam duration to a duration adapted to produce the first type of detectable lesion when applied at the maximum laser treatment beam power,

wherein the maximum laser treatment beam power and the adjusted laser treatment beam duration are used to determine the first Arrhenius integral value.

24. The non-transitory computer-readable storage medium of claim 21 , wherein adjusting at least one of the power and the duration of the laser treatment beam comprises:

adjusting the power of the laser treatment beam, wherein the duration of the laser treatment beam is kept constant.

25. The non-transitory computer-readable storage medium of claim 21 , wherein adjusting at least one of the power and the duration of the laser treatment beam comprises:

adjusting the duration of the laser treatment beam, wherein the power of the laser treatment beam is kept constant.

26. The non-transitory computer-readable storage medium of claim 21 , further comprising instructions for:

receiving a selection of a laser treatment beam diameter; and

in response to receiving the selection of the laser treatment beam diameter, adjusting the diameter of the laser treatment beam.

27. The non-transitory computer-readable storage medium of claim 21 , wherein the dose of laser energy adapted to produce the first type of detectable lesion represents a maximum energy value of the operating curve.

28. The non-transitory computer-readable storage medium of claim 21 , wherein the operating curve relates linear changes in energy value to exponential changes in Arrhenius integral values.

29. The non-transitory computer-readable storage medium of claim 28 , wherein receiving the selection corresponding to the data point of the set of data points that define the operating curve comprises:

receiving selection of a normalized energy value from a linear numerical scale of normalized energy values.

30. The non-transitory computer-readable storage medium of claim 21 , wherein at least one of the first type and the second type of detectable lesion is a sub-visible lesion.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2021
From: TOPCON MEDICAL LASER SYSTEMS, INC.
To: IRIDEX CORPORATION
Reel/Frame 056836/0849 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2016
From: SRAMEK, CHRIS
To: TOPCON MEDICAL LASER SYSTEMS, INC.
Reel/Frame 039469/0564 →
Continuity (2)
Continuation 13278066 · Oct 20, 2011
Related Publication 20160100984A1 · Apr 14, 2016